Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 3 records, 1 pages
Search For: Interferon Alpha-2a Biosimilar
Global Interferon Alpha-2a Biosimilar Supply, Demand and Key Producers, 2024-2030
10 Feb 2024
Pharma & Healthcare
Interferon Alpha-2a Biosimilar
The global Interferon Alpha-2a Biosimilar market size is expected to reach $ 99.7 million by 2030, rising at a market growth of -10.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Interferon Alpha-2a Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Interferon Alpha-2a Biosimilar
According to our (Global Info Research) latest study, the global Interferon Alpha-2a Biosimilar market size was valued at USD 217.1 million in 2023 and is forecast to a readjusted size of USD 99.7 million by 2030 with a CAGR of -10.5% during review period.
USD3480.00
Add To Cart
Global Interferon Alpha-2a Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Interferon Alpha-2a Biosimilar
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Interferon Alpha-2a Biosimilar
Total: 3 records, 1 pages
The global Interferon Alpha-2a Biosimilar market size is expected to reach $ 99.7 million by 2030, rising at a market growth of -10.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Interferon Alpha-2a Biosimilar market size was valued at USD 217.1 million in 2023 and is forecast to a readjusted size of USD 99.7 million by 2030 with a CAGR of -10.5% during review period.
USD3480.00
Add To Cart
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>